Bevacizumab/Carboplatin/Docetaxel Regimen

Preferred Label : Bevacizumab/Carboplatin/Docetaxel Regimen;

NCIt synonyms : Avastin/Carboplatin/Docetaxel; Carboplatin/Bevacizumab/Docetaxel; Docetaxel/Carboplatin/Bevacizumab; Carboplatin/Docetaxel/Bevacizumab; Bevacizumab/Carboplatin/Docetaxel; Docetaxel/Bevacizumab/Carboplatin; Bevacizumab-Carboplatin-Docetaxel;

NCIt definition : A regimen consisting of bevacizumab, carboplatin and docetaxel that can be used in the treatment of non-small cell lung cancer (NSCLC).;

NCI Metathesaurus CUI : CL1913062;

Details

Origin ID

C192895;

UMLS CUI

C5785494;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Bevacizumab [NCIt concept]
- Carboplatin [NCIt concept]
- Oxaliplatin [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Lung Non-Small Cell Carcinoma [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients